COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information for clinicians and patients is paramount. There have been a number of reports stating that non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate symptoms in COVID-19 patients. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Beth, Moss, Charlotte, Rigg, Anne, Van Hemelrijck, Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105332/
https://www.ncbi.nlm.nih.gov/pubmed/32256706
http://dx.doi.org/10.3332/ecancer.2020.1023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105332/
https://www.ncbi.nlm.nih.gov/pubmed/32256706
http://dx.doi.org/10.3332/ecancer.2020.1023

Ejemplares similares